Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Alpha-1 antitrypsin avoids epithelial to mesenchymal transition in ARPE-19 cells in a model of Diabetic Retinopathy

MARÍA CONSTANZA POTILINSKI; Juan Pablo Salica; Micaela Petrigliano; Eduardo Chuluyan; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5364.

ARVO Annual Meeting Abstract July 2018

Alpha-1 Antitrypsin Decreases Cx43 Expression Through PI3K/AKT Pathway in ARPE-19 Cells Exposed to High Glycemia

MARÍA CONSTANZA POTILINSKI; Gustavo Ortiz; Juan Pablo Salica; Emiliano López; Eduardo Chuluyán; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):196.

ARVO Annual Meeting Abstract July 2018

Alpha-1 Antitrypsin Decreases NFkB Signaling in Müller Cells in an in Vitro Diabetic Retinopathy Model.

Juan E Gallo; MARÍA CONSTANZA POTILINSKI; Gustavo Ortiz; Juan Pablo Salica; Emiliano López; Eduardo Chuluyán

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):201.

ARVO Annual Meeting Abstract June 2017

ALPHA-1-ANTITRYPSIN REDUCE LEVELS OF TUMOR NECROSIS FACTOR ALPHA BOTH IN VITRO AND IN VIVO DIABETES MODELS.

Juan E Gallo; Gustavo Ortiz; MARÍA CONSTANZA POTILINSKI; Juan Pablo Salica; Emiliano S Lopez; Eduardo Chuluyan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5805.

ARVO Annual Meeting Abstract September 2016

Antiangiogenic Effect of a Novel Fusion Protein PFMC inhibiting NFKB pathway on Corneal Alkali Injury Rat Model

Juan Pablo Salica; Alejandro Fichetti; Eduardo Chuluyan; Diego Guerrieri; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3514.

ARVO Annual Meeting Abstract September 2016

ALPHA-1 ANTITRYPSIN DIMINISHED ANGIOGENESIS IN HUMAN MICROVASCULAR CELLS EXPOSED TO HYPERGLYCEMIA.

Juan E Gallo; Gustavo Ortiz; Juan Pablo Salica; Eduardo Chuluyan

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4523.

ARVO Annual Meeting Abstract April 2014

Antiinflammatory and antiangiogenic effect of a novel Fusion Protein “SLPI and Cementoin” targeting NF-κB pathway

Juan Pablo Salica; Eduardo Chuluyan; Diego Guerrieri; Gustavo Ortiz; Juan E Gallo

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4725.

ARVO Annual Meeting Abstract April 2014

Chronological analyses of the expression of A1AT in the retina of diabetic rats

Gustavo Ortiz; Jorge Mancini; Juan Pablo Salica; Eduardo Chuluyan; Juan E Gallo; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4914.

ARVO Annual Meeting Abstract June 2013

Retinal Expression of α-1-Antitrypsin (A1AT) in diabetic and non-diabetic rats

Gustavo Ortiz; Jorge Mancini; Eduardo Chuluyan; Juan Gallo; Nanomedicine & Vision Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6329.

ARVO Annual Meeting Abstract March 2012

Intravitreal Administration of FP-MC, Inhibitor of Nuclear Factor KB, Reduced Retinal Immunoreactivity of TNF-a, IL-17, c-PLA2, and GFAP in Type 1 Diabetic Rats

Juan P. Salica; Jorge E. Mancini; Eduardo Chuluyan; Paulo Maffia; Diego Guerrieri; Juan E. Gallo

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2794.

ARVO Annual Meeting Abstract April 2011

Effect Of Topical Administration Of Slpi And Fp-mc, Inhibitors Of Nuclear Factor K B, In Rats With Corneal Alkali Burns, 7 Days Post Injury

Juan P. Salica; Eduardo Chuluyan; Juan E. Gallo; Paulo Maffia; Diego Guerrieri; Andrés Rodriguez

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2029.

Advertisement